HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo

This publication has 83 references indexed in Scilit:

• Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation
  Journal of Virology, 2001
• Role of CD40 Ligand Signaling in Defective Type 1 Cytokine Response in Human Immunodeficiency Virus Infection
  The Journal of Infectious Diseases, 2001
• The many roles of CD40 in cell-mediated inflammatory responses
  Immunology Today, 1996
• A central role of CD40 ligand in the regulation of CD4+ T-cell responses
  Immunology Today, 1996
• IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39
  Annual Review of Immunology, 1996
• The Ability of CD4+ Cells from HIV+ Individuals to Express CD40 Ligand after in Vitro Stimulation Is Not Impaired
  Clinical Immunology and Immunopathology, 1995
• Cell-Free HIV in Lymph Nodes of Patients with AIDS and Generalized Lymphadenopathy
  New England Journal of Medicine, 1988
• Nonrandom association of cellular antigens with HTLV-III virions
  Human Immunology, 1987
• Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.
  The Journal of Experimental Medicine, 1980
• Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells.
  The Journal of Experimental Medicine, 1979